A digital service from FCT Aromatase inhibitors in breast cancer: Signaling pathways involved in exemestane-acquired resistance.
Chicago Style (17th ed.) CitationAromatase Inhibitors in Breast Cancer: Signaling Pathways Involved in Exemestane-acquired Resistance.
MLA (9th ed.) CitationAromatase Inhibitors in Breast Cancer: Signaling Pathways Involved in Exemestane-acquired Resistance.
Warning: These citations may not always be 100% accurate.